BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $431,000 | -21.5% | 7,994 | -11.1% | 0.03% | -6.2% |
| Q2 2020 | $549,000 | +33.3% | 8,994 | +0.2% | 0.03% | +14.3% |
| Q1 2020 | $412,000 | -52.0% | 8,974 | -8.3% | 0.03% | -40.4% |
| Q4 2019 | $859,000 | -36.1% | 9,784 | -33.2% | 0.05% | -28.8% |
| Q3 2019 | $1,344,000 | -28.7% | 14,639 | -1.3% | 0.07% | -27.5% |
| Q2 2019 | $1,886,000 | – | 14,827 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |